Approval · Notice of Compliance 24794 · 2020
PROPADERM: Notice of Compliance 24794
Issued December 14, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24794
- Date
- December 14, 2020
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Change in the product ownership and label design element change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROPADERM | 02089602 | Marketed |
Medicinal ingredients
- BECLOMETHASONE DIPROPIONATE 0.025 PER